Edwards Lifesciences Corp
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 659,154 | 0.6% | 7,732,010 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 718,610 | 0.6% | 9,240,197 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 714,006 | 0.7% | 9,129,357 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 313,370 | 0.4% | 4,323,538 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 5,620 | 0.0% | 75,911 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 2,946 | 0.0% | 44,647 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 14,741 | 0.0% | 159,584 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 17,449 | 0.0% | 182,599 | 3/31/2024 |
| 2023 Q4 | 2/16/2024 | 37,257 | 0.0% | 488,620 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 101,053 | 0.1% | 1,458,617 | 9/30/2023 |
| 2023 Q2 | 5/17/2024 | 801,709 | 1.2% | 8,498,983 | 6/30/2023 |
| 2023 Q1 | 5/17/2024 | 639,494 | 1.1% | 7,729,896 | 3/31/2023 |
| 2022 Q4 | 5/17/2024 | 173,502 | 0.3% | 2,325,457 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 25,421 | 0.0% | 307,656 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 30,915 | 0.1% | 325,122 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 49,489 | 0.1% | 420,396 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 60,822 | 0.1% | 465,429 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 77,088 | 0.1% | 680,932 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 88,961 | 0.1% | 858,956 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 64,552 | 0.1% | 771,783 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 41,297 | 0.1% | 454,281 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 22,187 | 0.1% | 277,980 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 10,211 | 0.0% | 147,762 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 4,994 | 0.0% | 26,477 | 3/31/2020 |
| 2019 Q4 | 3/12/2020 | 6,154 | 0.0% | 26,477 | 12/31/2019 |